Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Par Pharmaceutical Companies
Par Pharmaceutical Companies
Activities:
Manufacturing
Pharmaceutical
X
LinkedIn
Trending Articles
Why smaller CDMOs should enhance their operational efficiency now: a CPHI expert guide
CPHI experts advise smaller CDMO's to invest in supply chain resilience, friend shoring and AI to keep up with the predicted uptick in funding for 2025
CPI collaborates with industry leaders to expedite drug manufacturing via digitisation
Digitising manufacturing technologies could allow enhanced ability to scale production, reduce costs and expedite the process
Adare expands global handling & packaging capabilities
The company will have enhanced compaction, milling, bin blending and tablet compression capabilities in Philadelphia, Ohio and Milan
Janssen to adopt Johnson & Johnson brand as the company celebrates 100 years of UK operation
The company's pharmaceutical and medical technology segments will combine under the Johnson & Johnson brand name in the UK
Making the most of each cell: single-use perfusion in biopharma processing
GEA kytero perfusion disk stack separators are pioneering the time- and cost-efficient harvesting of pharmaceutical proteins from cells and facilitating continuous processing,...
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Finance
Endo to purchase Par Pharmaceutical for US$8.05bn
Expanding generics business, product portfolio, pipeline and manufacturing capabilities
Manufacturing
Par Pharmaceutical to buy JHP Pharmaceuticals
Adds sterile injectable products to its portfolio
Finance
Par Pharmaceutical agrees to be acquired by private equity
US generics firm will continue to seek other buyers
Pharmaceutical
Par Pharmaceutical makes two promotions
To manage the expanded company and its subsidiaries
Finance
Par Pharmaceutical completes acquisition of Anchen
Purchase brings five commercialised products and 27 ANDAs on file with the US FDA
Finance
Par Pharmaceutical to pay US$410m for Anchen
Second acquisition of a privately held generics manufacturer this year
Finance
Par Pharmaceutical to acquire Edict Pharmaceuticals in India
Strengthens r&d and adds manufacturing capacity
Subscribe now